Press Release | ImmuneMed

Press Release | ImmuneMed

Press Release

Home

Company News

Publicity

[Heliyon] hzVSF inhibits hepatitis B virus infection by targeting viral cell entry

Writer|ImmuneMed

Views |220

Date|2022-05-26

Heliyon-hzVSF_HBV_%ED%8E%98%EC%9D%B4%EC%A7%80_1.jpg

Heliyon-hzVSF_HBV_%ED%8E%98%EC%9D%B4%EC%A7%80_2.jpg

Heliyon-hzVSF_HBV_%ED%8E%98%EC%9D%B4%EC%A7%80_3.jpg

Heliyon-hzVSF_HBV_%ED%8E%98%EC%9D%B4%EC%A7%80_4.jpg

Heliyon-hzVSF_HBV_%ED%8E%98%EC%9D%B4%EC%A7%80_5.jpg

Heliyon-hzVSF_HBV_%ED%8E%98%EC%9D%B4%EC%A7%80_6.jpg

Prev 및 Next
Prev	No Data
Next	[Journal of Clinical Medicine] COVID-19 Phase 2 Clinical Study Results 2022-05-26